MILD AUTONOMOUS CORTISOL SECRETION

Clinical trials for MILD AUTONOMOUS CORTISOL SECRETION explained in plain language.

Never miss a new study

Get alerted when new MILD AUTONOMOUS CORTISOL SECRETION trials appear

Sign up with your email to follow new studies for MILD AUTONOMOUS CORTISOL SECRETION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Low-Dose drug trial targets silent hormone problem

Disease control Recruiting now

This study is testing whether a very low 1 mg dose of the drug osilodrostat is safe and can help control mild, ongoing overproduction of the stress hormone cortisol from the adrenal glands. It will involve 15 adults who have a benign adrenal tumor and related health issues like h…

Matched conditions: MILD AUTONOMOUS CORTISOL SECRETION

Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC

MILD AUTONOMOUS CORTISOL SECRETION

Get alerted when new MILD AUTONOMOUS CORTISOL SECRETION trials appear

Low-Dose drug trial targets silent hormone problem